BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 19650027)

  • 1. [Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].
    Kandulski A; Venerito M; Malfertheiner P
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1635-40; quiz 1641-4. PubMed ID: 19650027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K
    Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
    Fosbøl EL; Køber L; Torp-Pedersen C; Gislason GH
    Expert Opin Drug Saf; 2010 Nov; 9(6):893-903. PubMed ID: 20569079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study.
    Lanas A; Tornero J; Zamorano JL
    Ann Rheum Dis; 2010 Aug; 69(8):1453-8. PubMed ID: 20498210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the benefits and risks of drugs. The example of NSAIDs.
    Henry D
    Aust Fam Physician; 1990 Mar; 19(3):378-83, 385, 387. PubMed ID: 2185729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disadvantageous effects of nonsteroidal anti-inflammatory drugs on the alimentary tract.
    Cichoz-Lach H; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):403-8. PubMed ID: 12898870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
    Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practice implications of cardiovascular risks in NSAIDs.
    Hainsworth T
    Nurs Times; 2005 Jun 28-Jul 4; 101(26):26-7. PubMed ID: 16010838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescription of non-steroidal anti-inflammatory drugs].
    Bannwarth B
    Bull Acad Natl Med; 1998; 182(7):1431-7; discussion 1437-8. PubMed ID: 9916337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ; Benraad HB; Rasker JJ
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
    Weber AA; Hohlfeld T; Harder S
    Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in the elderly.
    Sahi SP; Basu SK; Bansal SK
    Br J Clin Pract; 1990 Jan; 44(1):22-3, 27. PubMed ID: 2317434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs).
    Valkhoff VE; van Soest EM; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1218-28. PubMed ID: 20222917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
    Knights KM; Mangoni AA; Miners JO
    Br J Clin Pharmacol; 2006 Jun; 61(6):738-40. PubMed ID: 16722838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.